These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35012327)

  • 1. Our Efforts for Ideal Stroke Prevention and Treatment in Japan.
    Yamaguchi T
    Stroke; 2022 Mar; 53(3):1030-1036. PubMed ID: 35012327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
    Toyoda K; Uchiyama S; Yamaguchi T; Easton JD; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K;
    Lancet Neurol; 2019 Jun; 18(6):539-548. PubMed ID: 31122494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
    Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
    BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing Secondary Stroke Prevention Strategies: Optimal Timing of Dual Antiplatelet Therapy With Cilostazol.
    Madsen TE; de Havenon A
    Neurology; 2022 Mar; 98(10):387-388. PubMed ID: 35074892
    [No Abstract]   [Full Text] [Related]  

  • 5. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
    Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
    Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiplatelet therapy for secondary prevention of cerebral infarction].
    Tanahashi N
    Nihon Rinsho; 2014 Jul; 72(7):1270-5. PubMed ID: 25163320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial.
    Hoshino H; Toyoda K; Omae K; Ishida N; Uchiyama S; Kimura K; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
    Stroke; 2021 Nov; 52(11):3430-3439. PubMed ID: 34404237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention.
    Weber R; Diener HC
    J Cell Mol Med; 2010 Oct; 14(10):2371-80. PubMed ID: 20738445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of cilostazol for secondary stroke prevention: an old dog with new tricks?
    Ansara AJ; Shiltz DL; Slavens JB
    Ann Pharmacother; 2012 Mar; 46(3):394-402. PubMed ID: 22353234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cilostazol Mono and Combination Treatments in Ischemic Stroke: An Updated Systematic Review and Meta-Analysis.
    Kim SM; Jung JM; Kim BJ; Lee JS; Kwon SU
    Stroke; 2019 Dec; 50(12):3503-3511. PubMed ID: 31607242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and safety of multiple antiplatelet therapies for secondary prevention of ischemic stroke or transient ischemic attack: A network meta-analysis.
    Xiang RW; Han RB; Yang JY; Zhao MY; Zhao QC; Chen HS; Zhao FQ; Sun ZY; Zhao T; Song TY
    J Neurol Sci; 2019 Apr; 399():199-206. PubMed ID: 30849580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- vs. long-term dual antiplatelet therapy in secondary prevention for ischaemic stroke: a network metanalysis.
    Pugliese F; Arasaratnam P; Moellenberg M; Dani S
    Eur Heart J Qual Care Clin Outcomes; 2019 Oct; 5(4):298-309. PubMed ID: 31050716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 1-Year Outcomes of Triple (Aspirin + Clopidogrel + Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin + Clopidogrel + Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: from the DECREASE-PCI Trial.
    Lee CH; Lee JY; Park GM; Lee SW; Kim HS; Choi YJ; Nam CW; Cho JH; Shin WY; Seo JB; Choi SW; Lee JH; Min PK; Her SH; Lee PH; Ahn JM; Park DW; Kang SJ; Kim YH; Lee CW; Park SW; Park SJ
    Am J Cardiol; 2018 Feb; 121(4):423-429. PubMed ID: 29273207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilostazol for treatment of cerebral infarction.
    Noma K; Higashi Y
    Expert Opin Pharmacother; 2018 Oct; 19(15):1719-1726. PubMed ID: 30212227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol Addition to Aspirin could not Reduce the Neurological Deterioration in TOAST Subtypes: ADS Post-Hoc Analysis.
    Aoki J; Iguchi Y; Urabe T; Yamagami H; Todo K; Fujimoto S; Idomari K; Kaneko N; Iwanaga T; Terasaki T; Tanaka R; Yamamoto N; Tsujino A; Nomura K; Abe K; Uno M; Okada Y; Matsuoka H; Yamagata S; Yamamoto Y; Yonehara T; Inoue T; Yagita Y; Kimura K;
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105494. PubMed ID: 33278804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol Versus Standard Dual Antiplatelet in Patients With High Posttreatment Platelet Reactivity: Results of the CREATIVE Trial.
    Tang YD; Wang W; Yang M; Zhang K; Chen J; Qiao S; Yan H; Wu Y; Huang X; Xu B; Gao R; Yang Y;
    Circulation; 2018 May; 137(21):2231-2245. PubMed ID: 29420189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
    Wang Y; Chen W; Wang Y
    Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke.
    Guo JJ; Xu E; Lin QY; Zeng GL; Xie HF
    Neurosci Bull; 2009 Dec; 25(6):383-90. PubMed ID: 19927175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis.
    Lin MP; Meschia JF; Gopal N; Barrett KM; Ross OA; Ertekin-Taner N; Brott TG
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105581. PubMed ID: 33388632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis.
    Malloy RJ; Kanaan AO; Silva MA; Donovan JL
    Clin Ther; 2013 Oct; 35(10):1490-1500.e7. PubMed ID: 24139421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.